Nandrolone Decanoate (Deca-Durabolin) for Muscle & Joint Support — Anabolic Steroids
FDA-approved 19-nortestosterone derivative with potent anabolic properties and joint-protective effects.
Overview
Nandrolone Decanoate (Deca-Durabolin) is an FDA-approved anabolic steroid derived from 19-nortestosterone (lacking the C19 methyl group). It has one of the most favorable anabolic-to-androgenic ratios of any AAS, making it effective for lean tissue building with reduced androgenic side effects compared to testosterone. Its half-life of 6-8 days allows for weekly injection. Nandrolone aromatizes at only 20% the rate of testosterone, producing significantly less estrogenic side effects. It has documented joint-protective and collagen-stimulating properties, making it popular among individuals with joint issues. FDA-approved indications include anemia of chronic renal failure. Nandrolone acts as a progestogenic compound, which can cause unique side effects including prolactin elevation and sexual dysfunction ('deca dick') despite adequate testosterone levels.
Indications
- Anemia associated with chronic renal failure (FDA-approved)
- Muscle wasting in HIV/AIDS and chronic illness
- Osteoporosis and bone density preservation
- Joint pain and connective tissue support
- Sarcopenia and age-related muscle loss
- Post-surgical recovery and tissue repair
- Cachexia from chronic disease or cancer
- Burn recovery and nitrogen balance restoration
Mechanism of Action
Chronic conditions causing muscle loss, connective tissue deterioration, or inadequate red blood cell production
Dosing
| Compound | Dose | Frequency | Notes |
|---|---|---|---|
| Nandrolone Decanoate | 50-100 mg | Every 1-4 weeks | FDA-approved dose for anemia; conservative therapeutic dosing |
| Nandrolone Decanoate | 100-200 mg | Weekly | Joint support and moderate anabolic effect; always with testosterone base |
| Nandrolone Decanoate | 2 mg/kg | Weekly | Weight-based dosing for severe wasting conditions under medical supervision |
Evidence Grade
GRADE C
Safety & Contraindications
- FDA-approved for anemia of chronic renal failure at specific doses
- Schedule III controlled substance
- Progestogenic activity - can cause prolactin elevation and sexual dysfunction
- 'Deca dick' - erectile dysfunction possible even with adequate testosterone (manage with cabergoline)
- Low aromatization (20% of testosterone) but still monitor estradiol
- Suppresses natural testosterone profoundly - always co-administer with testosterone base
- Virilization risk in females at higher doses
- Monitor hepatic function with long-term use
- Cardiovascular risk: negative lipid profile changes (decreased HDL)
- Long detection time: metabolites detectable up to 18 months
- Contraindicated in prostate cancer, breast cancer, pregnancy